论文部分内容阅读
天鹅股份股价在并购消息的推动下不断升温,哈药集团跨行业收购天鹅股份的故事似乎并不简单。《新财经》记者将各方微妙关系细细梳理清楚之后,背后利益群体图穷匕现
Swan shares shares in the mergers and acquisitions news driven by the rising temperature, Harbin Pharmaceutical Group cross-sectoral Swan shares acquisition of the story does not seem simple. “New Finance” reporter carefully subtle relations between the parties carefully sort out the figure behind the dagger is poor